1.0Pharma Trendhttps://pharma-trend.com/enBusiness Wirehttps://pharma-trend.com/en/author/business/rich600338<blockquote class="wp-embedded-content" data-secret="14i3VZeleN"><a href="https://pharma-trend.com/en/casma-therapeutics-announces-ceo-transition/">Casma Therapeutics Announces CEO Transition</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://pharma-trend.com/en/casma-therapeutics-announces-ceo-transition/embed/#?secret=14i3VZeleN" width="600" height="338" title="“Casma Therapeutics Announces CEO Transition” — Pharma Trend" data-secret="14i3VZeleN" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script type="text/javascript"> /* <![CDATA[ */ /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); //# sourceURL=https://pharma-trend.com/en/wp-includes/js/wp-embed.min.js /* ]]> */ </script> CAMBRIDGE, Mass.–(BUSINESS WIRE)–Casma Therapeutics, a biotechnology company engaging the autophagy system to provide innovative new medicines, today announced that Keith Dionne, Ph.D., has stepped down as Chief Executive Officer, effective January 13, 2023. Dr. Dionne will continue to serve on the Board of Directors. Frank Gentile, Ph.D., formerly Chief Operating Officer of Casma, has been ... [Read more...]https://mms.businesswire.com/media/20230131005087/en/1698950/21/Casma-FullLogotype_PositiveFullColorRGB.jpg